REFERENCES
- Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19–28, 1995.
- White KP, Speechley M, Harth M, Ostbye T: The London fibromyalgia epidemiology study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26: 1570–1576, 1999.
- Branco JC, Saraiva F, Matucci Cerinic M, Zoppi M, Martin N, Taieb C, Myon E: Fibromyalgia syndrome: A European epidemiological survey. Ann Rheum Dis 64(Suppl III): 1784, 2005.
- Boonen A, van Den Heuvel R, van Tubergen A, Goossens M, Severens JL, van Der Heijde D, van der Linden S: Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 64: 396–402, 2005.
- Hughes G, Martinez C, Myon E, Taïeb C, Wessely S: The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis Rheum 54: 177–183, 2006.
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33: 160–172, 1990.
- Buskila D: Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 13: 117–27, 2001.
- Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, Smolen JS, Khaltaev N, Muirden KD: World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying anti-rheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 41: 86–89, 1994.
- Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Fibromyalgia syndrome. J Rheumatol 34: 1415–1425, 2007.
- Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Fibromyalgia syndrome. J Rheumatol 32: 2270–2277, 2005.
- Carville SF, Choy EH: Systematic review of discriminating power of outcome measures used in clinical trials of fibromyalgia. J Rheumatol 35: 2094–2105, 2008.
- Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73: 114–120, 2008.
- Carville SF, Choy EH: Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient Delphi exercises. Arthritis Rheum 59: 952–960, 2008.
- Katz RS, Wolfe F, Michaud K: Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54: 169–176, 2006.
- Wolfe F: The relation between tender points and fibromyalgia symptom variables: Evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56: 268–271, 1997.
- Moldofsky H, Scarisbrick P, England R, Smythe H: Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37: 341–351, 1975.